NEW YORK, NY / ACCESSWIRE / November 2, 2018 / U.S. markets rallied on Thursday, with the S&P 500 Index logging its first 3-day win streak in six weeks, as trade concerns between the U.S. and China continued to ease. The Dow Jones Industrial Average gained 1.06 percent to close at 25,380.74, while the S&P 500 Index increased 1.06 percent to close at 2,740.37. The Nasdaq Composite Index jumped 1.75 percent to close at 7,434.06.
“Equity markets were a sea of green yesterday, as risk appetite remained supported for another day. White House economic adviser Kudlow said that more tariffs on China are not ‘set in stone’, which may have boosted somewhat further market sentiment.” wrote Charalambos Pissouros, senior market analyst at brokerage and investment firm JFD Brokers, in a research note.
RDI Initiates Coverage on:
Alexion Pharmaceuticals, Inc.
OncoSec Medical Inc.
Alexion Pharmaceuticals’ stock jumped 6.81% Thursday, to close the day at $119.70. The stock recorded a trading volume of 1,912,412 shares, which was above its three months average volume of 1,607,826 shares. In the last year, Alexion Pharmaceuticals’ shares have traded in a range of 102.10 - 140.77. The share price has gained 17.24% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $124.80 is above its 200-day moving average of $122.42. Shares of Alexion Pharmaceuticals have fallen roughly 12.70 percent in the past month and are up 0.09 percent year-to-date.
Access RDI's Alexion Pharmaceuticals, Inc. Research Report at:
On Thursday, shares of OncoSec Medical recorded a trading volume of 4,398,918 shares, which was above the three months average volume of 1,152,584 shares. The stock ended the day 11.7% higher at $1.91. The share price has fallen 35.25% from its 52 week high with a 52 week trading range of 1.15 - 2.95. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $1.54 is above its 200-day moving average of $1.48. Shares of OncoSec Medical have gained roughly 36.43 percent in the past month and are up 17.18 percent year-to-date.
Access RDI's OncoSec Medical Inc. Research Report at:
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered
For any questions, inquiries, or comments reach out to us directly at:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.